Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 3/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | PDE2A | O00408 | 4/20 | 0.36 |
| ▸ | CRHR1 | P34998 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | TDO2 | P48775 | 1/20 | 0.35 |
| ▸ | KDR | P35968 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.33 |
| ▸ | TNF | P01375 | 1/20 | 0.33 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21187499 | 0.93 | DRD1 (0.35) | DRD1PTGS1PTGS2PDE2ACRHR1 | |
| SCHEMBL21187446 | 0.88 | HSD11B1 (0.39) | DRD1PTGS1PTGS2PDE2AHSD11B1 | |
| SCHEMBL21187501 | 0.84 | GRM8 (0.35) | PTGS1PTGS2ALDH1A1HTTGFER | |
| SCHEMBL21187488 | 0.83 | IDO1 (0.40) | DRD1PDE2ACRHR1IDO1TDO2 | |
| SCHEMBL21182369 | 0.81 | HSD11B1 (0.39) | PTGS1PTGS2PDE2AHSD11B1 | |
| SCHEMBL21187470 | 0.79 | PTGS1 (0.40) | PTGS1PTGS2CRHR1ALDH1A1HTT | |
| SCHEMBL21187459 | 0.78 | DPP4 (0.39) | PDE2AALDH1A1HSD11B1 | |
| SCHEMBL15688522 | 0.75 | DRD1 (0.53) | DRD1CRHR1 | |
| SCHEMBL20698033 | 0.74 | CRHR1 (0.37) | PTGS1PTGS2PDE2ACRHR1HSD11B1 | |
| SCHEMBL21187471 | 0.73 | HSD11B1 (0.39) | PTGS1PTGS2PDE2AHSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3740474-B1 | AGRICULTURAL CHEMICALS | GLOBACHEM NV (BE) | 2022-01-05 | — | — | EP | disclosed |
| US-20200339543-A1 | AGRICULTURAL CHEMICALS | GLOBACHEM NV (BE) | 2020-10-29 | — | — | US | disclosed |
| WO-2019141972-A1 | AGRICULTURAL CHEMICALS | GLOBACHEM NV (BE) | 2019-07-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200339543-A1 | AGRICULTURAL CHEMICALS | ABAT, BRDT, GABBR1 | DRD1 1273/4885PTGS1 2855/4885PTGS2 1986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.